Compounds > bradykinin, leu(8)-des-arg(9)-
Page last updated: 2024-09-03

bradykinin, leu(8)-des-arg(9)- and imidapril

bradykinin, leu(8)-des-arg(9)- has been researched along with imidapril in 1 studies

Compound Research Comparison

Studies
(bradykinin, leu(8)-des-arg(9)-)		Trials
(bradykinin, leu(8)-des-arg(9)-)		Recent Studies (post-2010)
(bradykinin, leu(8)-des-arg(9)-)		Studies
(imidapril)		Trials
(imidapril)		Recent Studies (post-2010) (imidapril)
102072386238

Protein Interaction Comparison

ProteinTaxonomybradykinin, leu(8)-des-arg(9)- (IC50)imidapril (IC50)
Angiotensin-converting enzyme Homo sapiens (human)9.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, M; Inoue, N; Kobayashi, K; Kondo, T; Li, P; Murohara, T; Numaguchi, Y; Okumura, K1

Other Studies

1 other study(ies) available for bradykinin, leu(8)-des-arg(9)- and imidapril

ArticleYear
Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:2

    Topics: Angiogenesis Inducing Agents; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Capillaries; Enzyme Inhibitors; Hindlimb; Imidazoles; Imidazolidines; Ischemia; Male; Mice; Mice, Knockout; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2008